Unlocking the health benefits of cannabinoids.

We are a team of medical experts.

Medical Advisory Board

Our Medical Advisory Board is made up of renowned Healthcare Professionals whose unique perspectives and expertise inform the strategic direction and success of the company.

Political Advisory Board

Our Political Advisory Board comprises renowned political experts and healthcare professionals who provide strategic guidance and advice to support Sanity Group to meet its mission and objectives.

Latest News

Sanity Group at the hemp fair Mary Jane and ICBC Berlin 2022

On July 15-17, 2022, Germany’s largest hemp fair “Mary Jane” will take place in Berlin. A few days later, on July 19 and 20, 2022, the International Cannabis Business Conference (ICBC) will also take place in Germany’s capital. The Sanity Group, one of Germany’s leading cannabis companies, will be represented at both events with booths, and is also a sponsor of the ICBC.

Read more

Vayamed and telemedicine pioneer Telaleaf launch exclusive partnership

German medical cannabis specialist Vayamed and the telemedicine platform Telaleaf agreed on an exclusive partnership to strengthen telemedicine in cannabis therapy in Germany. The focus will be on therapy quality, patient centered pricing, individual therapy plans, and equitable therapy access. Telaleaf is a pioneer in cannabis-based telemedicine from Canada established in 2020 and will now launch its services in the German healthcare system.

Read more

Endosane and UCI investigate the efficacy of new compounds for the treatment of PTSD

Endosane Pharmaceuticals and the University of California Irvine (UCI) have agreed to investigate the efficacy of two innovative compounds for the treatment of post-traumatic stress disorder (PTSD) through a series of preclinical studies. The studies will be conducted in the laboratory of the internationally renowned neuropharmacologist and leading endocannabinoid system researcher, Professor Daniele Piomelli. Results are expected as early as the first half of 2022.

Read more